Patent · US Active

Method for the chemical synthesis of oligonucleotides

US7777023B2 · kind B2 · utility

25Cited by

27References

20Claims

0Family size

Assignee

Sirna Therapeutics, Inc. · US

Inventors

Chandra Vargeese · Schwenksville, US
Christopher Shaffer · Craydon Court, US
Weimin Wang · Hangzhou City, CN

Key dates

Filing date	Oct 14, 2005
Grant date	Aug 17, 2010
Priority date	—
Expiry date	Mar 9, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/811
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention features novel compositions, linkers, derivatized solid supports, and methods for the efficient solid phase synthesis of oligonucleotides, including RNA, DNA, RNA-DNA chimeras, and analogs thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.